University of Kansas Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Kansas Medical Center sits in the top decile of US sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count).
University of Kansas Medical Center: 408 sponsored US clinical trials, 93 recruiting.
University of Kansas Medical Center sponsors 408 registered US clinical trials on ClinicalTrials.gov, 93 of them currently recruiting, and 252 completed. 28 of these trials are in Phase 3-4 (later-stage) and 85 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Smoking Cessation, with 9 trials.
Top-decile sponsor footprint
University of Kansas Medical Center ranks in the top decile of sponsors by registered trial count (#88 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
252 of 275 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
408 total, page 7 of 9
Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer
NCT03063125
Staying Strong and Healthy During Androgen Deprivation Therapy (ADT) for Men
NCT02969577
A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine
NCT03836664
Study of 1cm Versus 2cm Margins for the Surgical Treatment of cT2N0M0 Melanoma
NCT03034395
Budesonide for Mycophenolic Acid-induced Diarrhea in Renal Transplant Recipients
NCT02991768
Piloting At-birth Point of Care HIV Testing Strategies in Kenya
NCT03435887
Effect of Yoga on Mood and Quality of Life in Patients With Refractory Epilepsy
NCT02950636
Neuroimaging Studies of Practice and Smoking
NCT03080844
Feasibility of High Levels of Energy Expenditure From Physical Activity for Breast Cancer Survivors
NCT02963740
Changing the Default for Tobacco Treatment
NCT02721082
Application-based Perioperative Management of the Radical Cystectomy Patient
NCT02942121
Intervention to Reduce Sedentary Time
NCT02878486
Teen and Young Adult Connections for Support From Multidisciplinary Professionals & Peers
NCT02987569
Assessment of DHA On Reducing Early Preterm Birth
NCT02626299
Prenatal DHA and Neurofunctional Development
NCT02709239
Combined Application of Electrical Stimulation and Volitional Contractions for Muscle Strengthening and Knee Pain Inhibition (Seated Study)
NCT02802878
Text Messaging to Promote Walking Among Latino Adults at Risk for Peripheral Arterial Disease
NCT02622282
Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation
NCT02729701
The Feasibility of a Diet and Exercise Intervention in Diabetics During Treatment for Non-muscle Invasive Bladder Cancer
NCT02716623
Rasch-analysis of Clinical Severity in FSHD
NCT02766985
Feasibility Trial of a Mediterranean Diet Pattern to Prevent Cognitive Decline
NCT02921672
Rural Engagement in Primary Care for Optimizing Weight Reduction
NCT02456636
Combined Application of Electrical Stimulated Antagonist Contraction During Walking (Walking Study)
NCT02730598
Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
NCT02558595
Adapting the HITSystem to Support Prevention of Mother-to-child HIV Transmission
NCT02726607
Energy Expenditure of High Intensity Functional Training
NCT02526108
Remote Delivery of Weight Management by Phone and Social Media
NCT02496871
Effect of Extensively Hydrolyzed Liquid Human Milk Fortifier on Growth and Tolerance in Moderately Premature Infants
NCT02632266
Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers
NCT02244918
Telehealth Coaching for Families of Children With Autism
NCT02928068
Weight Management for Adolescents With IDD
NCT02561754
Neuroimaging Studies of Smoking and Treatment
NCT03085602
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations
NCT02260388
Effect of a Very Low Calorie and Low Calorie Diet on Moderate to Severe Obstructive Sleep Apnea in Obese Adults
NCT02251574
Ischemic Preconditioning to Prevent Acute Kidney Injury
NCT02167152
Smoking Cessation Versus Long-term Nicotine Replacement Among High-risk Smokers
NCT02148445
Impact of Exercise on Cognitive Impairment in End-Stage Renal Disease
NCT02145702
Liposomal Bupivacaine (Exparel) for Postoperative Pain Control for Open and Laparoscopic Abdominal Hernia Repair
NCT02128646
Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer
NCT02198859
Supporting Family Caregivers With Technology for Dementia Home Care
NCT02483520
Prevention of Ulnar Collateral Ligament (UCL) Injuries in Minor League Pitchers
NCT02749760
Alzheimer's Prevention Through Exercise
NCT02000583
Comparison of Collagenase With Antibiotic Ointment of Minor Partial Thickness Burns
NCT02673229
A Virtual Reality Intervention to Improve Weight Maintenance
NCT01841372
Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment
NCT02099266
Adaptation and Validation of a Nutrition Literacy Assessment Instrument
NCT02920099
Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome
NCT01863017
Cognitive Impairment and Imaging Correlates in End Stage Renal Disease
NCT01883349
A Pilot Study of Oxaloacetate in Subjects With Treated PD
NCT01741701
Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer
NCT00669162
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 40 |
| Phase 2 | 45 |
| Phase 3 | 9 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Kansas Medical Center pipeline
93 recruiting of 408 indexed (23% open); 252 completed (62%).
Phase mix: 28 late (III/IV) vs 85 early (I/II) (early-phase heavy).
Top condition: Smoking Cessation (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Kansas Medical Center: open-pipeline peers nationwide
Peers matched on 408 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
University of Kansas Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 408 trials (± recruiting share)
- Takeda · 408 trials · 12% recruiting
- Case Comprehensive Cancer Center · 407 trials · 14% recruiting
- University of Nebraska · 407 trials · 13% recruiting
- St. Jude Children's Research Hospital · 410 trials · 22% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Veterans Medical Research Foundation · 23% recruiting · 35 trials
- University of Delaware · 23% recruiting · 106 trials
- University of Texas at Austin · 23% recruiting · 257 trials
- Ohio State University Comprehensive Cancer Center · 23% recruiting · 341 trials
Related
What to do with this University of Kansas Medical Center page
408 registered trials is a research-attention snapshot, not an endorsement of University of Kansas Medical Center or any single study.
- 93 of University of Kansas Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Smoking Cessation is the condition University of Kansas Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Smoking Cessation trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Kansas Medical Center pipeline card: 408 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.